Innovative Drug Development Nurix Therapeutics specializes in developing innovative drugs that manipulate protein levels using ubiquitin E3 ligases, presenting an opportunity for partnerships with organizations seeking cutting-edge therapeutic approaches.
Industry Recognition Recent attention from analysts and investors towards Nurix Therapeutics' novel therapies for cancer and inflammatory diseases indicates a potential market demand for the company's unique drug development strategies.
Strategic Leadership Updates The strategic appointments of key personnel like Anil Kapur, Julia P. Gregory, and Pasit Phiasivongsa in various leadership roles suggest a forward-thinking vision that could attract collaborations and investment opportunities.
Financial Stability With a revenue range of $50-100 million and a funding of $175 million, Nurix Therapeutics demonstrates financial stability that could appeal to investors looking for opportunities in the biotechnology sector.
Market Presence & Expansion Nurix's participation in conferences and events like the Discovery on Target conference highlights its active presence in the market, showcasing potential avenues for networking, collaborations, and business expansion opportunities.
20
$10M
275$50M$100M
379$50M$100M
113$10M$50M
104$10M$50M
54$10M$50MNurix Therapeutics uses 8 technology products and services including GoTo Meeting, Akamai, Google Cloud, and more. Explore Nurix Therapeutics's tech stack below.
| Nurix Therapeutics Email Formats | Percentage |
| FLast@nurixtx.com | 78% |
| Last@nurixtx.com | 18% |
| First.Last@nurixtx.com | 4% |
| FLast@nurix-inc.com | 88% |
| Last@nurix-inc.com | 8% |
| First@nurix-inc.com | 1% |
| FMiddleLast@nurix-inc.com | 1% |
| F.Last@nurix-inc.com | 1% |
| LastF@nurix-inc.com | 1% |
Biotechnology ResearchCalifornia, United States201-500 Employees
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
Company Overview
Funding & FinancialsNurix Therapeutics has raised a total of $175M of funding over 8 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $175M.
Nurix Therapeutics's revenue is in the range of $50M$100M
Funding & FinancialsNurix Therapeutics has raised a total of $175M of funding over 8 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $175M.
Nurix Therapeutics's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com